Barcelona, Spain

Jordi Corbera Arjona

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Barcelona, ES (2007 - 2013)
  • Terrassa, ES (2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jordi Corbera Arjona

Introduction

Jordi Corbera Arjona is an influential inventor based in Barcelona, Spain. With a remarkable portfolio of five patents, he has made significant contributions to the fields of pharmaceuticals and medicinal chemistry. His work particularly emphasizes the development of compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Arjona has developed innovative substituted pyrazolo[3,4-d]pyrimidine compounds. These compounds exhibit a high affinity for sigma receptors, especially the sigma-1 receptor. This invention outlines not only the compounds themselves but also the processes for their preparation and their use in medicinal compositions. Another noteworthy patent focuses on substituted pyrazole sigma receptor antagonists, which have pharmacological activity towards sigma receptors. This invention encompasses pyrazole derivatives and their applications in treating conditions such as psychosis or pain.

Career Highlights

Jordi Corbera Arjona currently works at Laboratorios del Dr. Esteve S.A., where he applies his expertise in drug development and innovation. His pioneering work in synthesizing compounds that manipulate sigma receptors has garnered attention and respect within the scientific community.

Collaborations

Throughout his career, Arjona has collaborated with esteemed colleagues such as Joerg Holenz and David Vaño-Domenech. These professional partnerships have aided in the advancement of multiple projects and contribute to the successful development of new therapeutic compounds.

Conclusion

Jordi Corbera Arjona stands out as a dedicated inventor with promising contributions to medicinal chemistry. His innovative patents are set to pave the way for advancements in pharmacological therapies, showcasing his commitment to improving healthcare outcomes through science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…